DE2606257A1 - Recognine - Google Patents

Recognine

Info

Publication number
DE2606257A1
DE2606257A1 DE19762606257 DE2606257A DE2606257A1 DE 2606257 A1 DE2606257 A1 DE 2606257A1 DE 19762606257 DE19762606257 DE 19762606257 DE 2606257 A DE2606257 A DE 2606257A DE 2606257 A1 DE2606257 A1 DE 2606257A1
Authority
DE
Germany
Prior art keywords
malignin
astrocytin
tag
recognin
molecular weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19762606257
Other languages
German (de)
English (en)
Inventor
Samuel Dr Bogoch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE2606257A1 publication Critical patent/DE2606257A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4731—Recognins, e.g. malignin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57575—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncogenic proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE19762606257 1975-02-18 1976-02-17 Recognine Withdrawn DE2606257A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55043275A 1975-02-18 1975-02-18
US55307575A 1975-02-25 1975-02-25
US62111275A 1975-10-09 1975-10-09

Publications (1)

Publication Number Publication Date
DE2606257A1 true DE2606257A1 (de) 1976-08-26

Family

ID=27415588

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762606257 Withdrawn DE2606257A1 (de) 1975-02-18 1976-02-17 Recognine

Country Status (4)

Country Link
JP (2) JPH0146520B2 (https=)
CH (1) CH639102A5 (https=)
DE (1) DE2606257A1 (https=)
GB (1) GB1533464A (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0007214A1 (en) * 1978-07-07 1980-01-23 Samuel Dr. Bogoch Product for detecting the presence of cancerous or malignant tumor cells
DE3003301A1 (de) * 1979-01-30 1980-07-31 Otsuka Pharma Co Ltd Verfahren zur bestimmung von mit tumoren vorkommenden glykolbindungen enthaltende substanzen und testmittel zur durchfuehrung des verfahrens

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE8897T1 (de) * 1979-03-09 1984-08-15 Samuel Dr. Bogoch Recognine, ihre chemoreziprokale, am target haftende globuline und verfahren zur herstellung dieser produkte; verfahren zum bestimmen von krebstumoren.

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
Advances in experimental medicine and biology, 1972, (19), S.127-149 *
Chemical Abstracts 66, 814 x, 1967 *
Chemical Abstracts 68, 28 013 j, 1968 *
Chemical Abstracts 79, 88 494 d, 1973 *
Chemical Abstracts 82, 136 221 y, 1975 *
Chemical Abstracts 83, 25 812 t, 1975 *
Chemical Abstracts 83, 25 813 u, 1975 *
Chemical Anstracts 73, 31 466 t, 1970 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0007214A1 (en) * 1978-07-07 1980-01-23 Samuel Dr. Bogoch Product for detecting the presence of cancerous or malignant tumor cells
DE3003301A1 (de) * 1979-01-30 1980-07-31 Otsuka Pharma Co Ltd Verfahren zur bestimmung von mit tumoren vorkommenden glykolbindungen enthaltende substanzen und testmittel zur durchfuehrung des verfahrens

Also Published As

Publication number Publication date
GB1533464A (en) 1978-11-22
JPH01112163A (ja) 1989-04-28
JPH0146520B2 (https=) 1989-10-09
JPH0257671B2 (https=) 1990-12-05
CH639102A5 (en) 1983-10-31
JPS51108001A (https=) 1976-09-25

Similar Documents

Publication Publication Date Title
DE69823361T2 (de) Herstellung von kollagen
CH648330A5 (de) Tumor-spezifische glykoproteine und verfahren zu deren herstellung.
EP0220537B1 (de) Thymusextraktfraktionen enthaltende pharmazeutische Zusammensetzung
DE3877547T2 (de) Basisches protein phospholipase a2 aus dem gift der schlangen aus der familie der elapiden, deren aminosaeuresequenz, derivate und fragmente dieses proteins, verfahren um es zu erhalten, therapeutische kompositionen und diagnosemittel, alle dieses protein enthaltend und/oder dessen derivate und/oder dessen fragmente.
DE2546166A1 (de) Gegerbte thrombozyten
US4196186A (en) Method for diagnosing malignant gliol brain tumors
DE2538388B2 (de) Verfahren zur Herstellung eines stabilen, nicht-radioaktiven Trägermaterials für mit radioaktiven Elementen markierte Diagnosemittel und seine Verwendung für mit Tc-99m-markierte Diagnosemittel
DE3751316T2 (de) Materialzusammensetzung, welche ein Polypeptid aus Pankreas-Insel-Amyloid und/oder Antikörpern gegen dieses Polypeptid enthält, und Anwendung dieser Zusammensetzung.
US4195017A (en) Malignin, derived from brain tumor cells, complexes and polypeptides thereof
US4624932A (en) Recognins and their chemoreciprocals
DD202168A5 (de) Verfahren zur herstellung eines glycoproteins
DE60035267T2 (de) Verfahren zur analyse der menge an intraabdominalem fettgewebe
DE2606257A1 (de) Recognine
DE2546670A1 (de) Recognine
EP0007214A1 (en) Product for detecting the presence of cancerous or malignant tumor cells
DE2333740C2 (de) Verwendung eines Hämagglutinations-Hemmverfahrens zur Ermittlung von Krebs
CH639667A5 (de) Verfahren zur herstellung von peptidkomplexen aus dns-haltigen organismen.
US4624931A (en) Recognins and their chemoreciprocals
EP0253255A2 (de) Verfahren und Testkit zum Nachweis von Fibrinmonomeren im Blut
DE1903050A1 (de) Verfahren zur Feststellung und Lokalisation von neoplastischem Zellmaterial
AT293611B (de) Verfahren zur Feststellung von neoplastischem Zellmaterial
CA1057684A (en) Recognins and their chemoreciprocals
DE2815758C3 (de) Peptidkomplexe aus DNS-haltigen Organismen
DD140503A5 (de) Diagnostisches verfahren
JPS6362517B2 (https=)

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8139 Disposal/non-payment of the annual fee